Arcutis Biotherapeutics (ARQT) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to -$191.1 million.
- Arcutis Biotherapeutics' Enterprise Value rose 4219.89% to -$191.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$191.1 million, marking a year-over-year increase of 4219.89%. This contributed to the annual value of -$228.0 million for FY2024, which is 1615.02% up from last year.
- Arcutis Biotherapeutics' Enterprise Value amounted to -$191.1 million in Q3 2025, which was up 4219.89% from -$190.8 million recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' Enterprise Value ranged from a high of -$190.8 million in Q2 2025 and a low of -$477.0 million during Q3 2022
- Moreover, its 5-year median value for Enterprise Value was -$332.4 million (2023), whereas its average is -$322.4 million.
- Per our database at Business Quant, Arcutis Biotherapeutics' Enterprise Value plummeted by 9359.34% in 2021 and then surged by 5238.35% in 2023.
- Quarter analysis of 5 years shows Arcutis Biotherapeutics' Enterprise Value stood at -$387.1 million in 2021, then decreased by 5.82% to -$409.6 million in 2022, then soared by 33.63% to -$271.9 million in 2023, then increased by 16.15% to -$228.0 million in 2024, then rose by 16.18% to -$191.1 million in 2025.
- Its last three reported values are -$191.1 million in Q3 2025, -$190.8 million for Q2 2025, and -$198.1 million during Q1 2025.